Compass Therapeutics is a fully-integrated drug discovery and development company focused on manipulating the immune system to treat human disease using our proprietary Targeted Immunomodulation™ platform. Compass is initially focused on developing cures for cancer by comprehensively drugging the entire tumor-immune synapse with combination therapies. Novel scientific insights are validated and explored deeply inside our labs before Compass pursues the best proprietary combinations of therapeutics into human clinical trials.
Compass has attracted $170M in Series A financing to fund our ambitious plan to build a fully- integrated biopharmaceutical company from the ground up. Our investors are among the most sophisticated venture capitalists in the industry who exemplify our philosophy of building long term economic value through our therapeutic pipeline. They include OrbiMed Advisors, F-Prime Capital, Borealis Ventures, Thiel Capital, Cowen Private Investments, GV, and Alexandria Real Estate Ventures.
Thanks for visiting our Job Board. Please review our open positions and apply to the positions that match your qualifications.